3 Dividend Stocks Perfect for Retirees
These dividend stocks are built to last years and pay out regularly to boost your retirement income.
Allergan
AGN
AGN
$193.02
$0.03
0.0%
Price as of May 8, 2020, 4:15 p.m. EDT
View Interactive AGN Charts
The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.
Interactive Chart
News & Analysis: Allergan
The Fool has written over 300 articles on Allergan.
AbbVie's Pending Acquisition of Allergan Earns FTC Approval
With this final regulatory sign-off, the deal between these two pharmaceutical giants should close very soon.
How Safe Are AbbVie Stock and Its Dividend?
Is it possible to have both growth and safety in this market?
AbbVie Strikes Deal With the FTC to Move Its Allergan Acquisition Forward
The blockbuster pharmaceutical deal has had its share of detractors.
Editas and Allergan Make Gene-Editing History With First Treatment of Blindness Drug
It's the first time this type of gene-editing treatment has been tested on a human.
Allergan Sued by BTL Over False Advertising Claims Regarding Muscle-Toning Product
The pharmaceutical giant stands accused of making false and misleading product comparisons.
17 Consumer Groups and Unions Ask FTC to Block AbbVie's Acquisition of Allergan
The groups are worried about reduced competition if the merger goes through.
Allergan Pins Hopes on Millennials With Juvederm Marketing
It's all about the lips with the soon-to-be-acquired company's latest advertising push.
With Solid Fourth Quarter Results, AbbVie Shows That Its Growth Days Are Far From Over
Despite Humira's declining international sales, AbbVie is still worth considering.
How Allergan Beat Estimates in What's Likely Its Last Quarterly Update
The drugmaker delivered solid top- and bottom-line improvement as it awaited the closing of its acquisition by AbbVie.
